Innovative Technology Sommetrics' proprietary aer+ technology, which uses negative pressure to maintain airway patency, offers a non-invasive and well-tolerated solution for airway management, presenting a significant opportunity to target healthcare providers seeking advanced sleep disorder treatments.

Growing Sleep Market The recent launch of the aerSleep II device and its pivotal clinical trial demonstrate Sommetrics’ focus on sleep health innovations, opening doors to collaborate with hospitals and sleep clinics that are actively seeking effective alternatives to CPAP therapy.

FDA Recognition Receiving FDA Breakthrough Device designation positions Sommetrics' products as cutting-edge solutions with regulatory credibility, making them attractive to healthcare systems prioritizing innovative medical devices for airway management.

Strategic Leadership The appointment of experienced advisors and board members underscores the company's growth and strategic development efforts, signaling potential sales opportunities through partnerships and expanded clinical outreach within the medical community.

Funding & Validation With over $12 million in funding and revenue estimates between one to ten million dollars, Sommetrics is positioned for growth, creating opportunities to offer complementary products or services to expand its market share in sleep and airway management solutions.